Literature DB >> 32857646

Medication Adherence Trajectories: A Systematic Literature Review.

Mai Alhazami1, Vasco M Pontinha2, Julie A Patterson2, David A Holdford2.   

Abstract

BACKGROUND: Traditional adherence measures such as proportion of days covered (PDC) and medication possession ratio (MPR) are limited in their ability to explain patient medication adherence over time. Group-based trajectory modeling (GBTM) is a new methodological approach that visually describes the dynamics of long-term medication adherence and classifies adherence behavior into groups.
OBJECTIVES: To describe and compare trajectories of medication nonadherence reported in the medical literature, including identifying consistent trends in adherence trajectories and disease and patient characteristics that predict trajectory group membership.
METHODS: A systematic literature review was conducted in April 2020 in PubMed and CINAHL using MeSH terms and key words in appropriate combinations. Citations were screened for relevance using predefined inclusion and exclusion criteria and evaluated according to variables associated with group-based trajectory models.
RESULTS: 21 articles met the study criteria and were reviewed. Generally, studies identified 4 to 6 trajectory groups that described longitudinal medication adherence behavior. Most commonly identified trajectories were labeled as (a) consistent, high adherence, (b) declining adherence, (c) early and consistent nonadherence, and (d) initial nonadherence followed by an increase. Several predictors, including socioeconomic status, disease characteristics, and therapy initiation were routinely associated with group membership.
CONCLUSIONS: This review suggests that adherence trajectories and predictors of specific group membership may be similar across diverse disease states. GBTM describes longitudinal, dynamic patterns of medication adherence that may facilitate the development of targeted interventions to promote adherence. Implications for value-based payment systems are discussed in this review. DISCLOSURES: No outside funding supported this study. The authors have no conflicts of interest to declare.

Entities:  

Mesh:

Year:  2020        PMID: 32857646     DOI: 10.18553/jmcp.2020.26.9.1138

Source DB:  PubMed          Journal:  J Manag Care Spec Pharm


  9 in total

1.  Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy.

Authors:  Samuel W Terman; Wesley T Kerr; Zachary A Marcum; Lu Wang; James F Burke
Journal:  Epilepsia       Date:  2021-08-31       Impact factor: 5.864

2.  What methods are used to study the association between medication adherence trajectories, estimated with the group-based trajectory modeling (GBTM) method, and health-related outcomes?-a protocol for a systematic review.

Authors:  Victoria Memoli; Giraud Ekanmian; Sophie Lauzier; Line Guénette; Carlotta Lunghi; Anne-Déborah Bouhnik
Journal:  Syst Rev       Date:  2022-05-23

3.  Socio-cognitive determinants affecting insulin adherence/non-adherence in late adolescents and young adults with type 1 diabetes: a systematic review protocol.

Authors:  Hanan AlBurno; Liesbeth Mercken; Hein de Vries; Dabia Al Mohannadi; Stefan Jongen; Francine Schneider
Journal:  J Diabetes Metab Disord       Date:  2022-05-26

4.  Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies-An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden Countries.

Authors:  Liza M de Groot; Masja Straetemans; Noriah Maraba; Lauren Jennings; Maria Tarcela Gler; Danaida Marcelo; Mirchaye Mekoro; Pieter Steenkamp; Riccardo Gavioli; Anne Spaulding; Edwin Prophete; Margarette Bury; Sayera Banu; Sonia Sultana; Baraka Onjare; Egwuma Efo; Jason Alacapa; Jens Levy; Mona Lisa L Morales; Achilles Katamba; Aleksey Bogdanov; Kateryna Gamazina; Dzhumagulova Kumarkul; Orechova-Li Ekaterina; Adithya Cattamanchi; Amera Khan; Mirjam I Bakker
Journal:  Trop Med Infect Dis       Date:  2022-04-22

5.  Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries.

Authors:  Chelsea E Hawley; Julie C Lauffenburger; Julie M Paik; Deborah J Wexler; Seoyoung C Kim; Elisabetta Patorno
Journal:  Diabetes Care       Date:  2022-03-01       Impact factor: 19.112

6.  Persistence as a Robust Indicator of Medication Adherence-Related Quality and Performance.

Authors:  Enrica Menditto; Caitriona Cahir; Sara Malo; Isabel Aguilar-Palacio; Marta Almada; Elisio Costa; Anna Giardini; María Gil Peinado; Mireia Massot Mesquida; Sara Mucherino; Valentina Orlando; Carlos Luis Parra-Calderón; Enrique Pepiol Salom; Przemyslaw Kardas; Bernard Vrijens
Journal:  Int J Environ Res Public Health       Date:  2021-05-03       Impact factor: 3.390

7.  Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis.

Authors:  Jagadeswara R Earla; George J Hutton; J Douglas Thornton; Hua Chen; Michael L Johnson; Rajender R Aparasu
Journal:  Patient Prefer Adherence       Date:  2020-11-04       Impact factor: 2.711

8.  Identifying temporal patterns of adherence to antidepressants, bisphosphonates and statins, and associated patient factors.

Authors:  Kyu Hyung Park; Leonie Tickle; Henry Cutler
Journal:  SSM Popul Health       Date:  2021-11-19

9.  Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study.

Authors:  Irma Convertino; Sabrina Giometto; Rosa Gini; Massimiliano Cazzato; Marco Fornili; Giulia Valdiserra; Emiliano Cappello; Sara Ferraro; Claudia Bartolini; Olga Paoletti; Silvia Tillati; Laura Baglietto; Giuseppe Turchetti; Leopoldo Trieste; Valentina Lorenzoni; Corrado Blandizzi; Marta Mosca; Marco Tuccori; Ersilia Lucenteforte
Journal:  J Clin Med       Date:  2021-12-08       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.